Varian Medical Systems, Inc.  

(Public, NYSE:VAR)   Watch this stock  
Find more results for VAR
+0.84 (1.01%)
Oct 30 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 82.54 - 84.34
52 week 71.98 - 87.85
Open 82.74
Vol / Avg. 0.00/905,126.00
Mkt cap 8.58B
P/E 21.90
Div/yield     -
EPS 3.84
Shares 103.20M
Beta 0.92
Inst. own 92%
Jan 20, 2015
Q1 2015 Varian Medical Systems Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Nov 5, 2014
Varian Medical Systems Inc Year End Review in New York City - 11:30AM EST - Add to calendar
Oct 22, 2014
Q4 2014 Varian Medical Systems Inc Earnings Call
Oct 22, 2014
Q4 2014 Varian Medical Systems, Inc. Earnings Release
Sep 16, 2014
Varian Medical Systems Inc Investor Meeting @ ASTRO in San Francisco
Sep 4, 2014
Varian Medical Systems Inc at Robert W. Baird & Co. Inc Health Care Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin 13.04% 13.24%
Operating margin 19.60% 18.73%
EBITD margin - 19.55%
Return on average assets 12.43% 11.83%
Return on average equity 25.50% 24.24%
Employees 6,400 -
CDP Score - 84 C


3100 Hansen Way
PALO ALTO, CA 94304-1000
United States - Map
+1-650-4245834 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. The Company's Oncology Systems business segment designs, manufactures, sells and services hardware and software products for treating cancer with conventional radiotherapy, including IMRT, IGRT and volumetric modulated arc therapy, stereotactic body radiotherapy, stereotactic radiotherapy, stereotactic radiosurgery and brachytherapy. In August 2014, the Company acquired certain assets of Transpire, Inc., including Acuros dose calculation software that has been integrated into Varian's BrachyVision and Eclipse treatment planning software products.

Officers and directors

R. Andrew Eckert Independent Chairman of the Board
Age: 52
Bio & Compensation  - Reuters
Dow R. Wilson President, Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Elisha W. Finney Chief Financial Officer, Corporate Executive Vice President - Finance
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Clarence R. Verhoef Senior Vice President - Finance, Corporate Controller
Age: 58
Bio & Compensation  - Reuters
John W. Kuo Senior Vice President, General Counsel, Corporate Secretary
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kolleen T. Kennedy Senior Vice President, President - Oncology Systems
Age: 54
Bio & Compensation  - Reuters
Sunny Sanyal Senior Vice President; President, Imaging Components Businesses
Age: 49
Bio & Compensation  - Reuters
Susan L. Bostrom Independent Director
Age: 53
Bio & Compensation  - Reuters
Regina E. Dugan Ph.D. Independent Director
Age: 51
Bio & Compensation  - Reuters
David J. Illingworth Independent Director
Age: 60
Bio & Compensation  - Reuters